Genetic and functional analysis of the gene encoding neurogranin in schizophrenia

Schizophrenia Research

Volumn 137, Issue 1-3, 2012, Pages 7-13

  Shen, Yu Chih ^a,b   Tsai, Ho Min ^c   Cheng, Min Chih ^d   Hsu, Shih Hsin ^d   Chen, Shih Fen ^e   Chen, Chia Hsiang ^c,f  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d YULI VETERANS HOSPITAL   (Taiwan)

^e NATIONAL DONG HWA UNIVERSITY   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Association and functional study; NRGN; Rare variants; Schizophrenia

Indexed keywords

GENOMIC DNA;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CHINESE; COMPUTER ANALYSIS; CONTROLLED STUDY; EXON; GENE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; NEUROGRANIN GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; WILD TYPE;

ADULT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEUROGRANIN; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; TAIWAN;

EID: 84862795706     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.01.011     Document Type: Article

References (34)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.) 2000, American Psychiatric Association, Washington, DC.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Broadbelt K., Ramprasaud A., Jones L.B. Evidence of altered neurogranin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex. Schizophr. Res. 2006, 87:6-14.
4. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., Venturi P., Jones L.A., Lewis S.W., Sham P.C., Gottesman I.I., Farmer A.E., McGuffin P., Reveley A.M., Murray R.M. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 1999, 56:162-168.
5. Craddock N., O'Donovan M.C., Owen M.J. Phenotypic and genetic complexity of psychosis. Invited commentary on . . . Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 2007, 190:200-203.
6. Delisi L.E. Searching for the true genetic vulnerability for schizophrenia. Genome Med. 2009, 1:14.
7. den Dunnen J.T., Antonarakis S.E. Nomenclature for the description of human sequence variations. Hum. Genet. 2001, 109:121-124.
8. Dickson S.P., Wang K., Krantz I., Hakonarson H., Goldstein D.B. Rare variants create synthetic genome-wide associations. PLoS Biol. 2010, 8:e1000294.
9. Dowling A.L., Zoeller R.T. Thyroid hormone of maternal origin regulates the expression of RC3/neurogranin mRNA in the fetal rat brain. Brain Res. Mol. Brain Res. 2000, 82:126-132.
10. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
11. Gurling H.M., Kalsi G., Brynjolfson J., Sigmundsson T., Sherrington R., Mankoo B.S., Read T., Murphy P., Blaveri E., McQuillin A., Petursson H., Curtis D. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am. J. Hum. Genet. 2001, 68:661-673.
12. Huang K.P., Huang F.L., Jager T., Li J., Reymann K.G., Balschun D. Neurogranin/RC3 enhances long-term potentiation and learning by promoting calcium-mediated signaling. J. Neurosci. 2004, 24:10660-10669.
13. Iniguez M.A., Rodriguez-Pena A., Ibarrola N., Aguilera M., Munoz A., Bernal J. Thyroid hormone regulation of RC3, a brain-specific gene encoding a protein kinase-C substrate. Endocrinology 1993, 133:467-473.
14. International HapMap Consortium The International HapMap Project. Nature 2003, 426:789-796.
15. Li J., Pak J.H., Huang F.L., Huang K.P. N-methyl-d-aspartate induces neurogranin/RC3 oxidation in rat brain slices. J. Biol. Chem. 1999, 274:1294-1300.
16. Li T., Li Z., Chen P., Zhao Q., Wang T., Huang K., Li J., Li Y., Liu J., Zeng Z., Feng G., He L., Shi Y. Common variants in major histocompatibility complex region and TCF4 gene are significantly associated with schizophrenia in Han Chinese. Biol. Psychiatry 2010, 68:671-673.
17. Lichtenstein P., Yip B.H., Bjork C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009, 373:234-239.
18. Martinez de Arrieta C., Perez Jurado L., Bernal J., Coloma A. Structure, organization, and chromosomal mapping of the human neurogranin gene (NRGN). Genomics 1997, 41:243-249.
19. Martinez de Arrieta C., Morte B., Coloma A., Bernal J. The human RC3 gene homolog, NRGN contains a thyroid hormone-responsive element located in the first intron. Endocrinology 1999, 140:335-343.
20. McClellan J.M., Susser E., King M.C. Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 2007, 190:194-199.
21. Owen M.J., Williams H.J., O'Donovan M.C. Schizophrenia genetics: advancing on two fronts. Curr. Opin. Genet. Dev. 2009, 19:266-270.
22. Pak J.H., Huang F.L., Li J., Balschun D., Reymann K.G., Chiang C., Westphal H., Huang K.P. Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11232-11237.
23. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
24. Ran X., Miao H.H., Sheu F.S., Yang D. Structural and dynamic characterization of a neuron-specific protein kinase C substrate, neurogranin. Biochemistry 2003, 42:5143-5150.
25. Represa A., Deloulme J.C., Sensenbrenner M., Ben-Ari Y., Baudier J. Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate. J. Neurosci. 1990, 10:3782-3792.
26. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St Clair D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De Hert M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de Haan L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van Os J., van Winkel R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43:969-976.
27. Rodriguez-Sanchez P., Tejero-Diez P., Diez-Guerra F.J. Glutamate stimulates neurogranin phosphorylation in cultured rat hippocampal neurons. Neurosci. Lett. 1997, 221:137-140.
28. Ruano D., Aulchenko Y.S., Macedo A., Soares M.J., Valente J., Azevedo M.H., Hutz M.H., Gama C.S., Lobato M.I., Belmonte-de-Abreu P., Goodman A.B., Pato C., Heutink P., Palha J.A. Association of the gene encoding neurogranin with schizophrenia in males. J. Psychiatr. Res. 2008, 42:125-133.
29. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
30. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietilainen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Borglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Bottcher Y., Olesen J., Breuer R., Moller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Rethelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jonsson E.G., Terenius L., Agartz I., Petursson H., Nothen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
31. Storey J.D. A direct approach to false discovery rates. J. R. Stat. Soc. Ser. B 2002, 64:479-498.
32. Takeuchi F., Kobayashi S., Ogihara T., Fujioka A., Kato N. Detection of common single nucleotide polymorphisms synthesizing quantitative trait association of rarer causal variants. Genome Res. 2011, 21:1122-1130.
33. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 2002, 42:165-179.
34. Williams H.J., Owen M.J., O'Donovan M.C. Schizophrenia genetics: new insights from new approaches. Br. Med. Bull. 2009, 91:61-74.